Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Motor Activity 3Lung Neoplasms 2Esophageal Neoplasms 2Stomach Neoplasms 1Pediatric Brain Tumor 1Insulin Resistance 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Disease 1Brain Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 16Radiotherapy 15Drug Therapy 14Paclitaxel 13Cisplatin 12Carboplatin 10Immunotherapy 9Esophagectomy 9Radiation 8Fluorouracil 8Surgical Procedures, Operative 7Capecitabine 7Blood Specimen Collection 7Oxaliplatin 6Nivolumab 6Immune Checkpoint Inhibitors 6Chemoradiotherapy 6nimotuzumab 5Trastuzumab 5130-nm albumin-bound paclitaxel 5sintilimab 4camrelizumab 4Leucovorin 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Surveys and Questionnaires 3Endoscopy 3Bevacizumab 3toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Esophageal Neoplasms × High-Intensity Interval Training × Clear all
NCT07561840 2026-05-19

Exercise Training After Upper Gastrointestinal Cancer Surgery

Kansai Medical University

Phase NA Recruiting
171 enrolled
Gastrointestinal

Disease, Esophageal Neoplasms, Gastrointestinal Neoplasms, Motor Activity, Stomach Neoplasms

NCT07375420 2026-02-02

OPTIMUS

University of Surrey

Phase NA Recruiting
50 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡